The reported statements, read against the company's own industry.
Financials view
Market Capitalization
10.81BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Revenue (TTM)
4.03BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Profit Margin
-4.58%
vs Diagnostics & Research peers
Updated Jul 18, 2026
Beta
1.40x
vs all stocks
Updated Jul 18, 2026
52-Week Change
49.78%
vs all stocks
Updated Jul 18, 2026
Market Capitalization
10.81BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Enterprise Value
13.91BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Forward P/E
18.59x
vs Diagnostics & Research peers
Updated Jul 18, 2026
Price to Sales (TTM)
2.74x
vs Diagnostics & Research peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 2.68×.Updated Jul 18, 2026
Price to Book (MRQ)
3.75x
vs Diagnostics & Research peers
Updated Jul 18, 2026
Enterprise to Revenue
3.46x
vs Diagnostics & Research peers
Updated Jul 18, 2026
Enterprise to EBITDA
15.64x
vs Diagnostics & Research peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 17.68×.Updated Jul 18, 2026
Gross Margin
29.59%
vs Diagnostics & Research peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 34.46%.Updated Jul 18, 2026
Profit Margin
-4.58%
vs Diagnostics & Research peers
Updated Jul 18, 2026
Operating Margin
15.92%
vs Diagnostics & Research peers
Updated Jul 18, 2026
Return on Assets (TTM)
4.26%
vs Diagnostics & Research peers
Updated Jul 18, 2026
Return on Equity (TTM)
-5.87%
vs Diagnostics & Research peers
Updated Jul 18, 2026
Revenue (TTM)
4.03BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Revenue per Share (TTM)
81.96USDUpdated Jul 18, 2026
Quarterly Revenue Growth
1.20%
vs Diagnostics & Research peers
Updated Jul 18, 2026
Gross Profit (TTM)
1.39BUSD
vs all stocks (USD)
Updated Jul 18, 2026
EBITDA (TTM)
786.81MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Net Income (TTM)
-184.65MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Quarterly Earnings Growth (YoY)
1.18%
vs Diagnostics & Research peers
Updated Jul 18, 2026
Operating Cash Flow (TTM)
607.03MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Levered Free Cash Flow (TTM)
510.02MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Payout Ratio
0.00%
vs Diagnostics & Research peers
Updated Jul 18, 2026
Minority Interest (Equity)
46.56MUSDFY2025 · Dec 31, 2025
Revenue
4.02BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
2.69BUSDFY2025 · Dec 31, 2025
Gross Profit
1.32BUSDFY2025 · Dec 31, 2025
Operating Income
401.14MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-99.50MUSDFY2025 · Dec 31, 2025
Income Tax Expense
42.66MUSDFY2025 · Dec 31, 2025
Net Income
-142.16MUSDFY2025 · Dec 31, 2025
EBIT
7.53MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
786.81MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
743.07MUSDFY2025 · Dec 31, 2025
Non-operating Interest Income
4.94MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
107.03MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-2.91USDFY2025 · Dec 31, 2025
EPS (Diluted)
-2.91USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
49.56MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
49.56MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-142.16MUSDFY2025 · Dec 31, 2025
Minority Interests (P&L)
-2.17MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
194.22MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
216.00MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-142.16MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
403.31MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
-75.29MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
71.08MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
2.50MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
35.74MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
2.87MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-103.83MUSDFY2025 · Dec 31, 2025
Net Acquisitions
17.44MUSDFY2025 · Dec 31, 2025
Purchase of Investments
-20.08MUSDFY2025 · Dec 31, 2025
Sale of Investments
9.10MUSDFY2025 · Dec 31, 2025
Other Investing Activity
3.36MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
9.83MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
1.23BUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-1.35BUSDFY2025 · Dec 31, 2025
Common Stock Repurchase
-360.67MUSDFY2025 · Dec 31, 2025
Other Financing Charges
-54.98MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-537.44MUSDFY2025 · Dec 31, 2025
Shares Outstanding
48.17MSharesUpdated Jul 18, 2026
Float Shares
47.65MSharesUpdated Jul 18, 2026
Shares Short
4.35MSharesUpdated Jul 18, 2026
Short Ratio
5.13days
vs all stocks
Updated Jul 18, 2026
Short % of Shares Outstanding
10.43%
vs all stocks
Updated Jul 18, 2026
% Held by Insiders
0.64%
vs all stocks
Updated Jul 18, 2026
% Held by Institutions
123.34%
vs all stocks
Updated Jul 18, 2026
Total Cash (MRQ)
191.83MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Total Cash per Share (MRQ)
3.98USDUpdated Jul 18, 2026
Total Debt (MRQ)
3.06BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Total Debt to Equity (MRQ)
1.03x
vs Diagnostics & Research peers
Updated Jul 18, 2026
Current Ratio (MRQ)
1.36x
vs Diagnostics & Research peers
Updated Jul 18, 2026
Book Value per Share (MRQ)
61.05USDUpdated Jul 18, 2026
Total Assets
7.14BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.45BUSDFY2025 · Dec 31, 2025
Total Liabilities
3.92BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
5.69BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
2.80BUSDFY2025 · Dec 31, 2025
Total Current Liabilities
1.12BUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
213.77MUSDFY2025 · Dec 31, 2025
Accounts Receivable
518.73MUSDFY2025 · Dec 31, 2025
Inventory
299.10MUSDFY2025 · Dec 31, 2025
Accounts Payable
148.80MUSDFY2025 · Dec 31, 2025
Deferred Revenue
210.42MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
222.16MUSDFY2025 · Dec 31, 2025
Long-term Debt
2.57BUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
138.30MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
492.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
1.39BUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
3.21BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
0.00USDFY2025 · Dec 31, 2025
52-Week Low
144.26USDUpdated Jul 18, 2026
52-Week High
237.86USDUpdated Jul 18, 2026
52-Week Change
49.78%
vs all stocks
Updated Jul 18, 2026
Beta
1.40x
vs all stocks
Updated Jul 18, 2026
50-Day MA
190.07USDUpdated Jul 18, 2026
200-Day MA
183.56USDUpdated Jul 18, 2026
Avg 10-Day Volume
736.27KSharesUpdated Jul 18, 2026
Avg 30-Day Volume
817.45KSharesUpdated Jul 18, 2026
Diluted EPS (TTM)
-3.72USDUpdated Jul 18, 2026
Other Income / Expense
-398.55MUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
It reports a profit, and much of the gap to cash is depreciation rather than earnings.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Prioritizing buybacks over growth reinvestmentNotable